Claire Trainor1, Sasha Gorrell1, Elizabeth K Hughes2, Susan M Sawyer2, Claire Burton2, Daniel Le Grange1,3. 1. Department of Psychiatry, University of California, San Francisco, CA. 2. The University of Melbourne, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Australia. 3. Department of Paediatrics, The University of Chicago, Chicago, IL.
Abstract
OBJECTIVE: Rates of psychiatric comorbidity are elevated in adolescents with anorexia nervosa, but little is known about how psychiatric comorbidity changes following family-based treatment (FBT). METHODS:Adolescents with anorexia nervosa (N = 107) enrolled in a randomized controlled trial comparing two forms of FBT completed the Mini International Neuropsychiatric Interview for Children and Adolescents at baseline and end of treatment. Analyses tested whether baseline comorbid diagnoses predicted the presence of comorbid diagnoses at end of treatment and if baseline eating disorder psychopathology impacted this association. RESULTS:Rates of comorbid diagnoses decreased from 54% at baseline to 26% at end of treatment. Logistic regression analyses indicated that individuals with multiple comorbid diagnoses at baseline were more likely to meet criteria for a comorbid condition at end of treatment (b = 2.00, p < .05). Individuals with reported psychotropic medication use were less likely to meet criteria for a comorbid condition at end of treatment (b = -1.63, p = .04). Diagnostic rates for major depressive disorder, generalized anxiety disorder, and panic disorder/agoraphobia decreased following FBT. CONCLUSIONS: Findings suggest that FBT for adolescent anorexia nervosa may aid in the resolution of some co-occurring psychiatric diagnoses. Continued research is needed to understand factors contributing to comorbid symptom improvement throughout treatment.
RCT Entities:
OBJECTIVE: Rates of psychiatric comorbidity are elevated in adolescents with anorexia nervosa, but little is known about how psychiatric comorbidity changes following family-based treatment (FBT). METHODS: Adolescents with anorexia nervosa (N = 107) enrolled in a randomized controlled trial comparing two forms of FBT completed the Mini International Neuropsychiatric Interview for Children and Adolescents at baseline and end of treatment. Analyses tested whether baseline comorbid diagnoses predicted the presence of comorbid diagnoses at end of treatment and if baseline eating disorder psychopathology impacted this association. RESULTS: Rates of comorbid diagnoses decreased from 54% at baseline to 26% at end of treatment. Logistic regression analyses indicated that individuals with multiple comorbid diagnoses at baseline were more likely to meet criteria for a comorbid condition at end of treatment (b = 2.00, p < .05). Individuals with reported psychotropic medication use were less likely to meet criteria for a comorbid condition at end of treatment (b = -1.63, p = .04). Diagnostic rates for major depressive disorder, generalized anxiety disorder, and panic disorder/agoraphobia decreased following FBT. CONCLUSIONS: Findings suggest that FBT for adolescent anorexia nervosa may aid in the resolution of some co-occurring psychiatric diagnoses. Continued research is needed to understand factors contributing to comorbid symptom improvement throughout treatment.
Authors: David V Sheehan; Kathy H Sheehan; R Douglas Shytle; Juris Janavs; Yvonne Bannon; Jamison E Rogers; Karen M Milo; Saundra L Stock; Berney Wilkinson Journal: J Clin Psychiatry Date: 2010-03 Impact factor: 4.384
Authors: Stuart B Murray; Eva Pila; Daniel Le Grange; Susan M Sawyer; Elizabeth K Hughes Journal: Int J Eat Disord Date: 2017-09-15 Impact factor: 4.861
Authors: B Herpertz-Dahlmann; B Müller; S Herpertz; N Heussen; J Hebebrand; H Remschmidt Journal: J Child Psychol Psychiatry Date: 2001-07 Impact factor: 8.982
Authors: Katherine Schaumberg; Elisabeth Welch; Lauren Breithaupt; Christopher Hübel; Jessica H Baker; Melissa A Munn-Chernoff; Zeynep Yilmaz; Stefan Ehrlich; Linda Mustelin; Ata Ghaderi; Andrew J Hardaway; Emily C Bulik-Sullivan; Anna M Hedman; Andreas Jangmo; Ida A K Nilsson; Camilla Wiklund; Shuyang Yao; Maria Seidel; Cynthia M Bulik Journal: Eur Eat Disord Rev Date: 2017-10-02